Stem cell therapy for the treatment of early stage avascular necrosis of the femoral head: a systematic review

BMC Musculoskeletal Disorders

Rajiv Gandhi²  Nizar N Mahomed²  Safiyyah R Mahomed²  Heather MK Evans²  Anthony V Perruccio²  Rick L Lau¹ 

[1] Nickle 3, Kingston General Hospital, 76 Stuart Street, Kingston, ON K7L 2 V7, Canada;Division of Orthopaedic Surgery, Toronto Western Hospital, 399 Bathurst Street EW 1-427, Toronto, Ontario M5T 2S8, Canada

关键词: Precollapse;    Treatment;    Stem cells;    Femoral head;    Avascular necrosis;   

Others  :  1127624
DOI  :  10.1186/1471-2474-15-156

 received in 2014-01-08, accepted in 2014-05-07,  发布年份 2014

【 摘 要 】

Background

Avascular necrosis (AVN) of the femoral head (FH) is believed to be caused by a multitude of etiologic factors and is associated with significant morbidity in younger populations. Eventually, the disease progresses and results in FH collapse. Thus, a focus on early disease management aimed at joint preservation by preventing or delaying progression is key. The use of stem cells (SC) for the treatment of AVN of the FH has been proposed. We undertook a systematic review of the medical literature examining the use of SC for the treatment of early stage (precollapse) AVN of the FH, in both pre-clinical and clinical studies.

Methods

Data collected included: Pre-clinical studies – model of AVN, variety and dosage of SC, histologic and imaging analyses. Clinical studies – study design, classification and etiology of AVN, SC dosage and treatment protocol, incidence of disease progression, patient reported outcomes, volume of necrotic lesion and hip survivorship.

Results

In pre-clinical studies, the use of SC uniformly demonstrated improvements in osteogenesis and angiogenesis, yet source of implanted SC was variable. In clinical studies, groups treated with SC showed significant improvements in patient reported outcomes; however hip survivorship was not affected. Discrepancies regarding dose of SC, AVN etiology and disease severity were present.

Conclusions

Routine use of this treatment method will first require further research into dose and quality optimization as well as confirmed improvements in hip survivorship.

【 授权许可】

   
2014 Lau et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]Yoshioka T, Mishima H, Akaogi H, Sakai S, Li M, Ochiai N: Concentrated autologous bone marrow aspirate transplantation treatment for corticosteroid-induced osteonecrosis of the femoral head in systemic lupus erythematosus. Int Orthop 2011, 35:823-829. doi:10.1007/s00264-010-1048-y
• [2]Gangji V, De Maertelaer V, Hauzeur J-P: Autologous bone marrow cell implantation in the treatment of non-traumatic osteonecrosis of the femoral head: Five year follow-up of a prospective controlled study. Bone 2011, 49:1005-1009. doi:10.1016/j.bone.2011.07.032
• [3]Lee H-S, Huang G-T, Chiang H, Chiou L-L, Chen M-H, Hsieh C-H, Jiang C-C: Multipotential mesenchymal stem cells from femoral bone marrow near the site of osteonecrosis. Stem Cells 2003, 21:190-199. doi:10.1634/stemcells.21-2-190
• [4]Feitosa M-L-T, Fadel L, Beltrão-Braga P-C-B, Wenceslau C-V, Kerkis I, Kerkis A, Birgel Júnior E-H, Martins J-F, Martins Ddos S, Miglino M-A, Ambrósio C-E: Successful transplant of mesenchymal stem cells in induced osteonecrosis of the ovine femoral head: preliminary results. Acta Cir Bras 2010, 25:416-422.
• [5]Matsuya H, Kushida T, Asada T, Umeda M, Wada T, Iida H: Regenerative effects of transplanting autologous mesenchymal stem cells on corticosteroid-induced osteonecrosis in rabbits. Mod Rheumatol 2008, 18:132-139. doi:10.1007/s10165-008-0023-6
• [6]Sun Y, Feng Y, Zhang C: The effect of bone marrow mononuclear cells on vascularization and bone regeneration in steroid-induced osteonecrosis of the femoral head. Joint Bone Spine 2009, 76:685-690. doi:10.1016/j.jbspin.2009.04.002
• [7]Hernigou P, Beaujean F: Treatment of osteonecrosis with autologous bone marrow grafting. Clin Orthop Relat Res 2002, 405:14-23.
• [8]Zhao D, Cui D, Wang B, Tian F, Guo L, Yang L, Liu B, Yu X: Treatment of early stage osteonecrosis of the femoral head with autologous implantation of bone marrow-derived and cultured mesenchymal stem cells. Bone 2012, 50:325-330. doi:10.1016/j.bone.2011.11.002
• [9]Wang B-L, Sun W, Shi Z-C, Zhang N-F, Yue D-B, Guo W-S, Xu S-Q, Lou J-N, Li Z-R: Treatment of nontraumatic osteonecrosis of the femoral head with the implantation of core decompression and concentrated autologous bone marrow containing mononuclear cells. Arch Orthop Trauma Surg 2010, 130:859-865. doi:10.1007/s00402-009-0939-0
• [10]Abudusaimi A, Aihemaitijiang Y, Wang Y-H, Cui L, Maimaitiming S, Abulikemu M: Adipose-derived stem cells enhance bone regeneration in vascular necrosis of the femoral head in the rabbit. J Int Med Res 2011, 39:1852-1860.
• [11]Hang D, Wang Q, Guo C, Chen Z, Yan Z: Treatment of Osteonecrosis of the Femoral Head with VEGF (165) Transgenic Bone Marrow Mesenchymal Stem Cells in Mongrel Dogs. Cells Tissues Organs 2012, 195(6):495-506. doi:10.1159/000329502
• [12]Yan Z, Hang D, Guo C, Chen Z: Fate of mesenchymal stem cells transplanted to osteonecrosis of femoral head. J Orthop Res 2009, 27:442-446. doi:10.1002/jor.20759
• [13]Li Z-H, Liao W, Cui X-L, Zhao Q, Liu M, Chen Y-H, Liu T-S, Liu N-L, Wang F, Yi Y, Shao N-S: Intravenous transplantation of allogeneic bone marrow mesenchymal stem cells and its directional migration to the necrotic femoral head. Int J Med Sci 2011, 8:74-83.
• [14]Sen R-K, Tripathy S-K, Aggarwal S, Marwaha N, Sharma R-R, Khandelwal N: Early results of core decompression and autologous bone marrow mononuclear cells instillation in femoral head osteonecrosis: a randomized control study. J Arthroplasty 2012, 27:679-686. doi:10.1016/j.arth.2011.08.008
• [15]Yan Z-Q, Chen Y-S, Li W-J, Yang Y, Huo J-Z, Chen Z-R, Shi J-H, Ge J-B: Treatment of osteonecrosis of the femoral head by percutaneous decompression and autologous bone marrow mononuclear cell infusion. Chin J Traumatol 2006, 9:3-7.
• [16]Gangji V, Hauzeur J-P, Matos C, De Maertelaer V, Toungouz M, Lambermont M: Treatment of osteonecrosis of the femoral head with implantation of autologous bone-marrow cells. A pilot study. J Bone Joint Surg Am 2004, 86-A:1153-1160.
• [17]Song H-J, Lan B-S, Cheng B, Zhang K-F, Yan H-W, Wang W-Z, Gao Z-Q: Treatment of early avascular necrosis of femoral head by small intestinal submucosal matrix with peripheral blood stem cells. Transplant Proc 2011, 43:2027-2032. doi:10.1016/j.transproceed.2010.12.060
• [18]Gangji V, Hauzeur J-P: Cellular-based therapy for osteonecrosis. Orthop Clin North Am 2009, 40:213-221. doi:10.1016/j.ocl.2008.10.009
• [19]Gangji V, Toungouz M, Hauzeur J-P: Stem cell therapy for osteonecrosis of the femoral head. Expert Opin Biol Ther 2005, 5:437-442. doi:10.1517/14712598.5.4.437
• [20]Hernigou P, Poignard A, Manicom O, Mathieu G, Rouard H: The use of percutaneous autologous bone marrow transplantation in nonunion and avascular necrosis of bone. J Bone Joint Surg (Br) 2005, 87:896-902. doi:10.1302/0301-620X.87B7.16289
• [21]Gangji V, Hauzeur J-P: Treatment of osteonecrosis of the femoral head with implantation of autologous bone-marrow cells. Surgical technique. J Bone Joint Surg Am 2005, 87(Suppl 1):106-112. doi:10.2106/JBJS.D.02662
• [22]Hernigou P, Daltro G, Filippini P, Mukasa M-M, Manicom O: Percutaneous implantation of autologous bone marrow osteoprogenitor cells as treatment of bone avascular necrosis related to sickle cell disease. Open Orthop J 2008, 2:62-65. doi:10.2174/1874325000802010062
• [23]Kawate K, Yajima H, Ohgushi H, Kotobuki N, Sugimoto K, Ohmura T, Kobata Y, Shigematsu K, Kawamura K, Tamai K, Takakura Y: Tissue-engineered approach for the treatment of steroid-induced osteonecrosis of the femoral head: transplantation of autologous mesenchymal stem cells cultured with beta-tricalcium phosphate ceramics and free vascularized fibula. Artif Organs 2006, 30:960-962. doi:10.1111/j.1525-1594.2006.00333.x
• [24]Pak J: Autologous adipose tissue-derived stem cells induce persistent bone-like tissue in osteonecrotic femoral heads. Pain Physician 2012, 15:75-85.
• [25]Peng J, Wen C, Wang A, Wang Y, Xu W, Zhao B, Zhang L, Lu S, Qin L, Guo Q, Dong L, Tian J: Micro-CT-based bone ceramic scaffolding and its performance after seeding with mesenchymal stem cells for repair of load-bearing bone defect in canine femoral head. J Biomed Mater Res Part B Appl Biomater 2011, 96:316-325. doi:10.1002/jbm.b.31770
• [26]Xiao Z-M, Jiang H, Zhan X-L, Wu Z-G, Zhang X-L: Treatment of osteonecrosis of femoral head with BMSCs-seeded bio-derived bone materials combined with rhBMP-2 in rabbits. Chin J Traumatol 2008, 11:165-170.
• [27]Xu M, Peng D: Mesenchymal stem cells cultured on tantalum used in early-stage avascular necrosis of the femoral head. Med Hypotheses 2011, 76:199-200. doi:10.1016/j.mehy.2010.09.028
• [28]Yamasaki T, Yasunaga Y, Ishikawa M, Hamaki T, Ochi M: Bone-marrow-derived mononuclear cells with a porous hydroxyapatite scaffold for the treatment of osteonecrosis of the femoral head: a preliminary study. J Bone Joint Surg (Br) 2010, 92:337-341. doi:10.1302/0301-620X.92B3.22483
• [29]Song H-J: Peripheral Blood Stem Cell Transplantation for Ischemic Femoral Head Necrosis. Transplant Proc 2010, 42(7):2824. doi: 10.1016/j.transproceed.2010.02.077
• [30]Wen Q, Ma L, Chen Y-P, Yang L, Luo W, Wang X-N: Treatment of avascular necrosis of the femoral head by hepatocyte growth factor-transgenic bone marrow stromal stem cells. Gene Ther 2008, 15:1523-1535. doi:10.1038/gt.2008.110
• [31]Sun Y, Feng Y, Zhang C, Cheng X, Chen S, Ai Z, Zeng B: Beneficial effect of autologous transplantation of endothelial progenitor cells on steroid-induced femoral head osteonecrosis in rabbits. Cell Transplant 2011, 20:233-243. doi:10.3727/096368910X522234
• [32]Xie X-H, Wang X-L, He Y-X, Liu Z, Sheng H, Zhang G, Qin L: Promotion of bone repair by implantation of cryopreserved bone marrow-derived mononuclear cells in a rabbit model of steroid-associated osteonecrosis. Arthritis Rheum 2012, 64:1562-1571. doi:10.1002/art.34525
• [33]Wen Q, Jin D, Zhou C-Y, Zhou M-Q, Luo W, Ma L: HGF-transgenic MSCs can improve the effects of tissue self-repair in a rabbit model of traumatic osteonecrosis of the femoral head. PLoS One 2012, 7:e37503. doi:10.1371/journal.pone.0037503
• [34]Aimaiti A, Saiwulaiti Y, Saiyiti M, Wang Y-H, Cui L, Yusufu A: Therapeutic effect of osteogenically induced adipose derived stem cells on vascular deprivation-induced osteonecrosis of the femoral head in rabbits. Chin J Traumatol 2011, 14:215-220.
• [35]Hernigou P, Poignard A, Zilber S, Rouard H: Cell therapy of hip osteonecrosis with autologous bone marrow grafting. Indian J Orthop 2009, 43:40-45. doi:10.4103/0019-5413.45322
• [36]Hernigou P, Beaujean F, Lambotte J-C: Decrease in the mesenchymal stem-cell pool in the proximal femur in corticosteroid-induced osteonecrosis. J Bone Joint Surg (Br) 1999, 81:349-355.
• [37]Jones E, Yang X: Mesenchymal stem cells and bone regeneration: current status. Injury 2011, 42:562-568. doi:10.1016/j.injury.2011.03.030
• [38]Rackwitz L, Eden L, Reppenhagen S, Reichert JC, Jakob F, Walles H, Pullig O, Tuan R-S, Rudert M, Nöth U: Stem cell- and growth factor-based regenerative therapies for avascular necrosis of the femoral head. Stem Cell Res Ther 2012, 3:7. doi:10.1186/scrt98 BioMed Central Full Text
• [39]Suh K-T, Kim S-W, Roh H-L, Youn M-S, Jung J-S: Decreased osteogenic differentiation of mesenchymal stem cells in alcohol-induced osteonecrosis. Clin Orthop Relat Res 2005, 431:220-225.
• [40]Mont M-A, Jones L-C, Hungerford D-S: Nontraumatic osteonecrosis of the femoral head: ten years later. J Bone Joint Surg Am 2006, 88:1117-1132. doi:10.2106/JBJS.E.01041
• [41]Jones L-C, Hungerford D-S: Osteonecrosis: etiology, diagnosis, and treatment. Curr Opin Rheumatol 2004, 16:4343-4449.
• [42]Hauzeur J-P, Gangji V: Phases 1–3 clinical trials using adult stem cells in osteonecrosis and nonunion fractures. Stem Cells Int 2010, 2010:410170. doi:10.4061/2010/410170
• [43]Cuende N, Rico L, Herrera C: Concise Review: Bone Marrow Mononuclear Cells for the Treatment of Ischemic Syndromes: Medicinal Product or Cell Transplantation? Stem Cells Trans Med 2012, 1(5):403-408.
• [44]Iwase T, Nagaya N, Fujii T, Itoh T, Murakami S, Matsumoto T, Kangawa K, Kitamura S: Comparison of Angiogenic Potency Between Mesenchymal Stem Cells and Mononuclear Cells in a Rat Model of Hindlimb Ischemia. Cardiovasc Res 2005, 66:543-551.
• [45]Lu D, Chen B, Liang Z, Deng W, Jiang Y, Li S, Xu J, Wu Q, Zhang Z, Xie B, Chen S: Comparison of Bone Marrow Mesenchymal Stem Cells with Bone Marrow-Derived Mononuclear Cells for Treatment of Diabetic Critical Limb Ischemia and Foot Ulcer: A Double-Blind, Randomized Controlled Trial. Diabetes Res Clin Pract 2011, 92(1):26-36.
• [46]Samdani A-F, Paul C, Betz R-R, Fischer I, Neuhuber B: Transplantation of Human Marrow Stromal Cells and Mono-Nuclear Bone Marrow Cells into the Injured Spinal Cord: A Comparative Study. Spine (Phila Pa 1976) 2009, 34(24):2605-2612.
• [47]Ikebe C, Suzuki K: Mesenchymal Stem Cells for Regenerative Therapy: Optimization of Cell Preparation Protocols. Biomed Res Int 2014, 2014:951512.
• [48]Jones K-B, Seshadri T, Krantz R, Keating A, Ferguson P-C: Cell-based therapies for osteonecrosis of the femoral head. Biol Blood Marrow Transplant 2008, 14:1081-1087. doi:10.1016/j.bbmt.2008.06.017
• [49]Sen R-K: Management of avascular necrosis of femoral head at pre-collapse stage. Indian J Orthop 2009, 43:6-16. doi:10.4103/0019-5413.45318
• [50]Schallmoser K, Bartmann C, Wagner W: Replicative Senescence-Assosiated Gene Expression Changes in Mesenchymal Stromal Cells are Similar under Different Culture Conditions. Haematologica 2010, 95(6):867-874.
• [51]Pamphilon D, Mijovic A: Storage of Hemopoietic Stem Cells. Asian J Transfus Sci 2007, 1(2):71-76.
• [52]Boss J-H, Misselvich I: Osteonecrosis of the Femoral Head of Laboratory Animals: The Lessons Learned from a Comparative Study of Osteonecrosis in Man and Experimental Animals. Vet Pathol 2003, 40(4):345-354.
• [53]Wang C, Wang J, Zhang Y, Yuan C, Liu D, Pei Y, Li X, Wu Z, Li Y, Guo Z: A Canine Model of Femoral Head Osteonecrosis Induced by an Ethanol Injection Navigated by a Novel Template. Int J Med Sci 2013, 10(11):1451-1458.